Lobbying client

VIFOR PHARMA LTD

Pharmaceutical Company.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
61
Filed by
2
Reported in-house
—
Reported by firms
$2,210,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2012 to 2025

Filings

61 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination
3rd Quarter 2025
SIDLEY AUSTIN LLP — reported
2nd Quarter - Report
2nd Quarter 2025
SIDLEY AUSTIN LLP — reported
1st Quarter - Report
1st Quarter 2025
SIDLEY AUSTIN LLP $20,000 reported
4th Quarter - Report (No Activity)
4th Quarter 2024
SIDLEY AUSTIN LLP — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2024
SIDLEY AUSTIN LLP — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2024
SIDLEY AUSTIN LLP — reported
1st Quarter - Report (No Activity)
1st Quarter 2024
SIDLEY AUSTIN LLP — reported
4th Quarter - Report
4th Quarter 2023
SIDLEY AUSTIN LLP — reported
3rd Quarter - Report
3rd Quarter 2023
SIDLEY AUSTIN LLP — reported
2nd Quarter - Report
2nd Quarter 2023
SIDLEY AUSTIN LLP $20,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
SIDLEY AUSTIN LLP 55 $2,060,000
TODD STRATEGY GROUP 3 $150,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 50
Medicare/Medicaid MMM 7

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 1576 114th 7
H.R. 1576 115th 4

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.